DocGo Inc. Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
DocGo Inc. (DCGO) reported Business Combination, Consideration Transferred, Equity Interests Issued and Issuable of $4.00 million for the 34-month period ending 2025-12-30, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred
us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable · last filed 2026-03-16
- DocGo Inc. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2023-12-31 was $0.00.
- DocGo Inc. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2023-09-30 was $0.00.
- DocGo Inc. business combination, consideration transferred, equity interests issued and issuable for fiscal 2023 was $4.00M.
| Period end | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 3 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 6 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 9 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 12 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 15 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 22 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 34 month |
|---|---|---|---|---|---|---|---|
| 2025-12-30 | $4.00M 10-K · filed 2026-03-16 | ||||||
| 2025-02-10 | $1.00M 10-Q · filed 2025-11-10 | ||||||
| 2024-07-02 | $4.00M 10-K · filed 2025-02-27 | ||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $4.00M 10-K · filed 2024-02-28 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $4.00M 10-Q · filed 2023-11-06 | |||||
| 2023-06-30 | $4.00M 10-Q · filed 2023-08-08 | ||||||
| 2023-04-02 | $4.00M 10-Q · filed 2024-08-07 | ||||||
| 2023-04-01 | $4.00M 10-Q · filed 2024-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |